Loading people...
Anurag Mehta is a Principal at Johnson & Johnson Innovation based in the San Francisco Bay Area, where he leads strategic investments and partnerships across the medtech, diagnostics, and therapeutics sectors. Before joining this corporate venture capital group in 2022, he served as a Venture Partner at ARCH Venture Partners and a Principal at Versant Ventures. Throughout his investing career, Mehta has been involved in funding more than 20 early-stage startups, which includes notable portfolio exits such as the 2020 acquisition of Grail. He holds a PhD in Chemical Engineering from UC Berkeley and recently directed a new corporate investment in a synthetic biology enterprise during the first quarter of 2024. As an innovation leader, Mehta currently focuses on bridging academic research with commercial biotechnology development to advance early-stage healthcare, digital health, and life sciences innovations.
Anurag Mehta serves as a Principal at Johnson & Johnson Innovation, a pivotal role within one of the world's leading healthcare companies. In this capacity, Mr. Mehta is instrumental in identifying, evaluating, and executing strategic investments in groundbreaking healthcare solutions. His work directly supports Johnson & Johnson's overarching mission to discover and develop transformative innovations that address significant unmet medical needs globally.
At Johnson & Johnson Innovation, Mr. Mehta's primary focus lies in early-stage investments across a diverse spectrum of life sciences and medical technology. He actively seeks out promising companies and technologies in areas such as pharmaceuticals, medical devices, diagnostics, and digital health. These investments are not merely financial; they represent strategic partnerships designed to accelerate the development of novel therapies and technologies, bringing them closer to patients who need them most. His expertise is particularly valuable in navigating the complex landscape of biotech and medtech startups, identifying those with the potential to significantly impact patient outcomes.
Mr. Mehta's investment focus aligns with Johnson & Johnson's broad therapeutic areas of interest, which typically include oncology, immunology, neuroscience, cardiovascular and metabolic diseases, and infectious diseases. He is keen on innovations that offer disruptive approaches to disease treatment, prevention, and diagnosis. This includes advancements in precision medicine, gene therapy, cell therapy, and innovative digital platforms that enhance patient care and health management. His strategic vision helps to build a robust pipeline of future healthcare solutions for Johnson & Johnson.
While specific details of Mr. Mehta's career background prior to Johnson & Johnson Innovation are not publicly detailed, his role as a Principal suggests a strong foundation in venture capital, corporate development, or a related field within the healthcare industry. Professionals in such positions typically possess a deep understanding of scientific principles, market dynamics, and financial analysis, enabling them to make informed decisions on high-potential investments. His contributions are vital in fostering an ecosystem where scientific breakthroughs can translate into tangible health benefits.
Through his dedicated efforts, Anurag Mehta plays a critical role in shaping the future of healthcare. By forging strategic alliances and providing essential capital and expertise to innovative startups, he helps Johnson & Johnson Innovation remain at the forefront of medical advancement. His commitment ensures that cutting-edge research and development receive the necessary support to evolve from concept to reality, ultimately improving the lives of countless individuals worldwide.
Anurag Mehta is a Principal at Johnson & Johnson Innovation, where he focuses on strategic investments in early-stage healthcare companies and technologies.
He invests in early-stage life sciences, medical technology, diagnostics, and digital health companies, aligning with Johnson & Johnson's therapeutic areas of interest like oncology, immunology, and neuroscience.
Anurag Mehta works at Johnson & Johnson Innovation, a division of Johnson & Johnson dedicated to fostering healthcare innovation through strategic partnerships and investments.